Faculty

Beatriz M. Carreno, PhD

faculty photo
Research Professor of Pathology and Laboratory Medicine
Department: Pathology and Laboratory Medicine
Graduate Group Affiliations

Contact information
PCAM South Tower, 8th Floor
3400 Civic Blvd
Philadelphia, PA 19104
Office: 215-573-7044
Lab: 215-573-4931
Education:
BS
Universidad Simon Bolivar, Caracas, Venezuela, 1981.
PhD (Microbiology)
Georgetown University School of Medicine, 1989.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Bushara, O., Linette, G.P., Carreno, B.M.: Designing universal T cell therapies: Strategies to evade Natural Killer cells. Frontiers in Immunol May 2026 Notes: in press.

Apodaca K., Xu C, Stanton K.L., Baroja M.L., Alfaro Doblado A.R., Engel N.W., Wellhauusen N., Cox A., Berjis A., Ji M.Q., Bushara O., Melendez D., Welch C., Banerjee E., Assenmacher C.A., Sheppard N.C., Scholler J., June C.H., Carreno B.M., Linette G.P.: HLA-E single-chain trimer shields gene-edited allogeneic CAR T Cells from NK cell attack. Blood Adv Apr 2026 Notes: Epub ahead of print.

Wang G., Yoon D., Nandi A., Patel K., Azar T., Kim J., Han N.A., Nickie A., Park S., Wang K., Yan P., Divaker S., Tabita-Martinez J., Giles L., Carberry M., Beltra J.C., Painter M.M., Alanio C., Amaravadi R.K., Schuchter L.M., Carreno B.M., Linette G.P., Elder D.E., Brody R.M., Gimotty P., Miura J.T., Karakousis G.C., Xu X., Mitchell T.C., Huang A.C.: Antigen-specific profiling identifies T-bet+ melanoma -specific CD8+ T cells associated with response to neoadjuvant PD-1 blockade. Cancer Cell 44(1): 221-234, Jan 2026.

Benton A., Liu J., Poussin M.A., Lang Goldgewicht A., Udawela M., Bear A.S., Wellhausen N., Carreno B.M., Smith P.M., Beasley M.D., Kiefel B.R., Powell D.J. Jr: Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy. Cancer Cell 43(7): 1365-1376.e5, Jul 2025 Notes: doi: 10.1016/j.ccell.2025.05.006. Epub 2025 Jun 5. PMID: 40480232

Blanchard T., Faridi P., Xu C., Bear A.S., Rasool R.U., Huang G., Lim T.C.C., Ayala R., Gabunia K., Ji M., Posey A.D. Jr, Scholler J., Asangani I.A., Purcell A.W., Linette G.P., June C.H., Carreno B.M.: LOXHD1 is an oncofusion-regulated antigen of ewing sarcoma. Sci Rep 15(1): 13007, Apr 2025 Notes: doi: 10.1038/s41598-025-96877-9. PMID: 40234527 Free PMC article.

Porazzi P., Nason S., Yang Z., Carturan A., Ghilardi G., Guruprasad P., Patel R.P., Tan M., Padmanabhan A.A., Lemoine J., Fardella E., Zhang Y., Pajarillo R., Chen L., Ugwuanyi O., Markowitz K., Delman D., Angelos M.G., Shestova O., Isshiki Y., Blanchard T., Béguelin W., Melnick A.M., Linette G.P., Beatty G.L., Carreno B.M., Cohen I.J., Paruzzo L., Schuster S.J., Ruella M.: EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models. Cancer Cell 43(3): 537-551.e7, Mar 2025 Notes: doi: 10.1016/j.ccell.2025.01.013. Epub 2025 Feb 20. PMID: 39983725

Bear A.S., Nadler R.B., O'Hara M.H., Stanton K.L., Xu C., Saporito R.J., Rech A.J., Baroja M.L., Blanchard T., Elliott M.H., Ford M.J., Jones R., Patel S., Brennan A., O'Neil Z., Powell D.J. Jr, Vonderheide R.H., Linette G.P., Carreno B.M.: Natural TCRs targeting KRASG12V display fine specificity and sensitivity to human solid tumors. J Clin Invest 134(21): e175790, Sep 2024 Notes: doi: 10.1172/JCI175790. PMID: 39287991 Free PMC article. Clinical Trial.

Patel, R.P., Ghilardi, G., Zhang, Y., Chiang, Y., Xie, W., Guruprasad, P., Kim, K., Chun, I., Angelos, M.G., Pajarillo, R., Hong, S., Lee, Y., Shestova, O., Shaw, C., Cohen, I., Gupta, A., Vu, T., Qian, D., Yang, S., Nimmagadda, A., Snook, A.E., Siciliano, N., Rotolo, A., Inamdar, A., Harris, J., Ugwuanyi, O., Wang, M., Carturan, A., Paruzzo, L., Chen, L., Ballard, H.J., Blanchard, T., Xu, C., Abdel-Mohsen, M., Gabunia, K., Wysocka, M., Linette, G.P., Carreno, B.M., Barrett, D.M., Teachey, D.T., Posey, A.D., Powell Jr., D.J., Sauter, C.T., Pileri, S., Pillai, V., Scholler, J., Rook, A.H., Schuster, S.J., Barta, S.K., Porazzi, P., Ruella, M.: CD5 deletion enhances the antitumor activity of adoptive T cell therapies. Sci Immunol 9(97): eadn6509, Jul 2024.

Linette GP, Bear AS, Carreno BM: Facts and hopes in immunotherapy strategies targeting antigens derived from KRAS mutations. Clin Cancer Res Jan 2024 Notes: doi: 10.1158/1078-0432.CCR-23-1212. Online ahead of print.

Lee IK, Sharma N, Noguera-Ortega E, Liousia M, Baroja ML, Etersque JM, Pham J, Sarkar S, Carreno BM, Linette GP, Puré E, Albelda SM, Sellmyer MA.: A genetically encoded protein tag for control and quantitative imaging of CAR T cell therapy. Mol Ther 31(12): 3564-3578, Dec 2023.

back to top
Last updated: 05/11/2026
The Trustees of the University of Pennsylvania